Literature DB >> 17494105

Facilitation of decidualization by locally produced ghrelin in the human endometrium.

N Tawadros1, L A Salamonsen, E Dimitriadis, C Chen.   

Abstract

Ghrelin acting via the growth hormone secretagogue receptor (GHS-R) stimulates GH secretion from pituitary glands. Both ligand and receptor are present in the pituitary, hypothalamus and many peripheral tissues including the uterus. This study demonstrates the cyclical expression of GHS-R and ghrelin in human endometrium. mRNA and protein for ghrelin and GHS-R were examined using RT-PCR and immunohistochemistry. Both ghrelin and GHS-R mRNA levels were highest in the secretory phase, with lower levels in the mid-proliferative phase and even lower expression in the menstrual phase. Immunoreactive ghrelin and GHS-R were confined predominantly to glandular epithelial and stromal cells with the greatest intensity of staining in secretory phase samples, consistent with the RT-PCR data. Additionally, we examined ghrelins effect on the decidualization of human endometrial stromal cells (HESCs) combined with sex steroid and cAMP treatments using prolactin (PRL) and insulin-like growth factor binding protein-1 (IGFBP-1) production as markers of decidualization. Ghrelin administered in combination with sex steroids to HESC, resulted in an increase in PRL and IGFBP-1 production above that obtained with cAMP, or sex steroids alone (P<0.001) whereas ghrelin in combination with cAMP inhibits the action of cAMP. These findings have potential clinical applications for the regulation of fertility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17494105     DOI: 10.1093/molehr/gam029

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  9 in total

1.  Differential expression and regulation of Ido2 in the mouse uterus during peri-implantation period.

Authors:  Dang-Dang Li; Xin-Yuan Liu; Chuan-Hui Guo; Liang Yue; Zhan-Qing Yang; Hang Cao; Bin Guo; Zhan-Peng Yue
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-11-19       Impact factor: 2.416

2.  Expression and in vitro functions of the ghrelin axis in endometrial cancer.

Authors:  Jenny N T Fung; Inge Seim; Dengfeng Wang; Andreas Obermair; Lisa K Chopin; Chen Chen
Journal:  Horm Cancer       Date:  2010-10       Impact factor: 3.869

3.  Maternal ghrelin deficiency compromises reproduction in female progeny through altered uterine developmental programming.

Authors:  J Ryan Martin; Sarah B Lieber; James McGrath; Marya Shanabrough; Tamas L Horvath; Hugh S Taylor
Journal:  Endocrinology       Date:  2011-02-15       Impact factor: 4.736

4.  Ghrelin in the human myometrium.

Authors:  Margaret O'Brien; Padraig Earley; John J Morrison; Terry J Smith
Journal:  Reprod Biol Endocrinol       Date:  2010-05-28       Impact factor: 5.211

5.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

6.  Ghrelin negatively affects the function of ovarian follicles in mature pigs by direct action on basal and gonadotropin-stimulated steroidogenesis.

Authors:  Agnieszka Rak-Mardyła; Anna Wróbel; Ewa L Gregoraszczuk
Journal:  Reprod Sci       Date:  2014-09-11       Impact factor: 3.060

Review 7.  The Role of the Gastric Hormones Ghrelin and Nesfatin-1 in Reproduction.

Authors:  Martha A Schalla; Andreas Stengel
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

8.  Effect of Ghrelin on Hepatic IGF-Binding Protein-1 Production.

Authors:  Moira S Lewitt
Journal:  ISRN Obes       Date:  2013-01-17

Review 9.  New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides.

Authors:  Ewa Mlyczyńska; Marta Kieżun; Patrycja Kurowska; Monika Dawid; Karolina Pich; Natalia Respekta; Mathilde Daudon; Edyta Rytelewska; Kamil Dobrzyń; Barbara Kamińska; Tadeusz Kamiński; Nina Smolińska; Joelle Dupont; Agnieszka Rak
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.